Endovascular Stent market
Endovascular Stent Market Study by Endovascular Aneurysm Repair Stents, Fenestrated EVAR, Aortic Stents, and Others in Ambulatory Surgical Centers and Others From 2024 to 2034
Analysis of Endovascular Stent Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Endovascular Stent Market Outlook (2024 to 2034)
According to a new industry report released by Fact.MR, turnover of the global endovascular stent market is estimated at US$ 1.32 billion in 2024 and is forecasted to expand at 8.5% CAGR to achieve a value of US$ 2.99 billion by the end of 2034.
The market growth for endovascular stents is driven by the rising prevalence of cardiovascular diseases, such as peripheral artery diseases, aneurysms, atherosclerosis, and others. For individuals suffering from vascular illnesses, these minimally invasive devices are becoming essential for reestablishing blood flow and averting consequences. Treatment results are enhanced by advancements in stent technology, such as drug-eluting stents, bioresorbable stents, and stent grafts. These developments are contributing to the endovascular stent market growth by providing increased efficacy, fewer problems, and faster recovery times.
In 2024, North America is projected to hold 36.6% of the worldwide market share because of its advanced healthcare system and high rate of cardiovascular diseases. The market is growing in the region due to the existence of top medical device producers and ongoing advancements in stent technology, including drug-eluting stents. The South Asia & Pacific market is forecasted to register a CAGR of 10.4% from 2024 to 2034 with rising incidence of cardiovascular diseases and increasing healthcare expenditure.
Based on product, endovascular aneurysm repair (EVAR) stents are estimated to account for 36.2% share of the overall revenue in 2024 because they come under a minimally invasive approach that offers substantial advantages over traditional open surgery for the treatment of abdominal aortic aneurysms (AAA). EVAR stents are a favored alternative for patients, especially those who are elderly or have significant surgical risks, as they shorten recovery times, limit problems, and lessen the risk of infection. The need for EVAR stents is also driven by the rising incidence of aneurysms, especially in the elderly population, and the developments in stent design that lead to better results and longer endurance.
| Report Attribute | Detail |
|---|---|
| Endovascular Stent Market Size (2024E) | US$ 1.32 Billion |
| Forecasted Market Value (2034F) | US$ 2.99 Billion |
| Global Market Growth Rate (2024 to 2034) | 8.5% CAGR |
| North America Market Share (2024E) | 36.6% |
| Western Europe Market Value (2024E) | US$ 282.45 Million |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 10.4% CAGR |
| Endovascular Aneurysm Repair (EVAR) stent Segment Value (2034F) | US$ 1.12 Billion |
| Abdominal Aortic Aneurysm (AAA) Segment Value (2034F) | US$ 1.73 Billion |
| Key Companies Profiled | Abbott Laboratories; Boston Scientific Co.; Medtronic plc; Cardinal Health, Inc.; B. Braun Melsungen AG; Biotronik Se & Co.; Cook Medical, Inc.; Terumo Co.; Microport Scientific Co.; Meril Life Sciences Pvt. Ltd.; C.R. Bard; Vascular Concepts Ltd.; VentureMed, Inc.; W.L. Gore and Associates, Inc.; Endologix, Inc.; Translumina GmbH; Lombard Medical Technologies. |
An endovascular stent is a fabric tube grafted during endovascular surgery to treat an aneurysm through several surgical invasive procedures. The technological advancement in the field of surgical areas from open surgeries to endovascular surgeries upsurge the demand for endovascular stents.
According to the American Heart Association, the United States set out to have more than 48% of cardiovascular patients in 2019. Additionally, in 2015 according to CDC data estimation, more than 6,00,000 patients were fatal each year in the United States owing to the increased prevalence of abdominal aortic aneurysm (AAA), which was considered as the top cause of the mortality.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Endovascular Stent Market: Drivers and Restraints
The rising prevalence of aneurysm disease and the cardiac complications within the growing geriatric population are the major factors that are expected to drive the endovascular stent market growth during the forecast period. The frequent occurrence of ailments, such as cardiovascular disorders, aortic aneurysms, or artery disease and inclination to minimally invasive surgical procedures has led to propelling the endovascular stent market growth.
Furthermore, attribution to superior lifestyle choices such as alcohol consumption, smoking, and unhealthy diet habits of an individual has been led to a rise in the incidence of cardiovascular diseases that projected to drive the endovascular stent market during the forecast period. The high cost of the treatment and the associated complications are expected to restrain the endovascular stent market growth during the forecast period.
Endovascular Stent Market: Overview
The global endovascular stent market manifests considerable growth during the forecast period owing to the rise in the prevalence of cardiovascular complications. Based on the product, the endovascular aneurysm repair (EVAR) stent segment holds the largest share owing to the technological advancement in surgical devices anticipated by the rising demand for EVAR stents in the global endovascular stent market.
Based on the application, the abdominal aortic aneurysm (AAA) segment dominated the endovascular stent market due to the increased prevalence of abdominal aortic aneurysm incidence in the region. Hospitals and cardiovascular centers dominate the end-user segment owing to the availability of advanced medical devices, ease of treatment, with health policy assurance facilities.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Endovascular Stent Market: Region-wise Outlook
North America expects to dominate the endovascular stent market during the forecast period owing to the increasing prevalence of cardiovascular disease, acquired advanced treatment, and availability of reimbursement. Europe is the second leading region due to the rise in geriatric population and rising adoption of medical devices in the region. South Asia and East Asia regions witnessed significant growth during the forecast period due to the initiation of the regional government, and increasing healthcare expenditure that is expected to drive the endovascular stent market.
Other regions like Latin America and Middle East and Africa are emerging regions in the endovascular stent market.
Endovascular Stent Market: Leading Key Players
The major players contributing to endovascular stent market are Abbott Laboratories, Boston Scientific Co., Medtronic plc, Cardinal Health, Inc., B. Braun Melsungen AG, Biotronik Se & Co., Cook Medical, Inc., Terumo Co., Microport Scientific Co., Meril Life Sciences Pvt Ltd., C.R. Bard, Vascular Concepts Ltd., VentureMed, Inc., W.L. Gore and Associates, Inc., Endologix, Inc., Translumina GmbH, Lombard Medical Technologies, and others.
The research report on the endovascular stent market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on the market provides analysis and information according to market segments such as products, applications, and end users.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Europe (Germany, Italy, France, UK, Spain, Russia)
- East Asia (China, Japan, South Korea)
- South Asia (India, ASEAN)
- Oceania (Australia, New Zealand)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Segmentation of Endovascular Stent Market Research
-
By Product :
- Endovascular Aneurysm Repair (EVAR) Stents
- Fenestrated EVAR
- Aortic Stents
- Thoracic Aortic Aneurysm Graft Stents
-
By Application :
- Thoracic Aortic Aneurysm
- Abdominal Aortic Aneurysm (AAA)
-
By End User :
- Hospitals & Cardiovascular Centers
- Ambulatory Surgical Centers
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Product 6.2. Application 6.3. End User 7. Global Market Analysis and Forecast, By Product 7.1. Endovascular aneurysm repair (EVAR) stent 7.2. Fenestrated EVAR 7.3. Aortic stents 7.4. Thoracic aortic aneurysm graft stents 7.5. Others 8. Global Market Analysis and Forecast, By Application 8.1. Thoracic Aortic Aneurysm 8.2. Abdominal aortic aneurysm (AAA) 9. Global Market Analysis and Forecast, By End User 9.1. Hospitals & Cardiovascular centers 9.2. Ambulatory Surgical Centers 9.3. Others 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia & Pacific 10.7. MEA 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries 17. MEA Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Product, Application, and End User for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Abbott Laboratories 20.2. Boston Scientific Co. 20.3. Medtronic plc 20.4. Cardinal Health, Inc. 20.5. B. Braun Melsungen AG 20.6. Biotronik Se & Co. 20.7. Cook Medical, Inc. 20.8. Terumo Co. 20.9. Microport Scientific Co. 20.10. Meril Life Sciences Pvt Ltd. 20.11. C.R. Bard 20.12. Vascular Concepts Ltd. 20.13. VentureMed, Inc. 20.14. W.L. Gore and Associates, Inc. 20.15. Endologix, Inc. 20.16. Translumina GmbH 20.17. Lombard Medical Technologies
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Product
Table 3: Global Market US$ Mn Forecast by Application
Table 4: Global Market US$ Mn Forecast by End User
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Product
Table 7: North America Market US$ Mn Forecast by Application
Table 8: North America Market US$ Mn Forecast by End User
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Product
Table 11: Latin America Market US$ Mn Forecast by Application
Table 12: Latin America Market US$ Mn Forecast by End User
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Product
Table 15: Western Europe Market US$ Mn Forecast by Application
Table 16: Western Europe Market US$ Mn Forecast by End User
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Product
Table 19: Eastern Europe Market US$ Mn Forecast by Application
Table 20: Eastern Europe Market US$ Mn Forecast by End User
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Product
Table 23: East Asia Market US$ Mn Forecast by Application
Table 24: East Asia Market US$ Mn Forecast by End User
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Product
Table 27: South Asia & Pacific Market US$ Mn Forecast by Application
Table 28: South Asia & Pacific Market US$ Mn Forecast by End User
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Product
Table 31: MEA Market US$ Mn Forecast by Application
Table 32: MEA Market US$ Mn Forecast by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is driving the demand outlook for the endovascular stent market?
The technological advancement in the field of surgical areas from open surgeries to endovascular surgeries upsurges endovascular stents demand.
Where will the growth spearhead in the endovascular stent market?
North America is projected to witness noteworthy growth over the forecast period.
Which are the top players in the market?
Key players are Abbott Laboratories, Boston Scientific Co., Medtronic plc, Cardinal Health, Inc., and B. Braun Melsungen AG.
Endovascular Stent market